Bryan Yoon
2021 - Terns Pharmaceuticals
In 2021, Bryan Yoon earned a total compensation of $1.5M as Chief Operating Officer, General Counsel and Secretary at Terns Pharmaceuticals, a 54% decrease compared to previous year.
Compensation breakdown
| Bonus | $8,133 |
|---|---|
| Non-Equity Incentive Plan | $187,067 |
| Option Awards | $867,082 |
| Salary | $406,667 |
| Other | $7,500 |
| Total | $1,476,449 |
Yoon received $867.1K in option awards, accounting for 59% of the total pay in 2021.
Yoon also received $8.1K in bonus, $187.1K in non-equity incentive plan, $406.7K in salary and $7.5K in other compensation.
Rankings
In 2021, Bryan Yoon's compensation ranked 7,316th out of 12,406 executives tracked by ExecPay. In other words, Yoon earned more than 41.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,316 out of 12,406 | 41st |
Division Manufacturing | 3,207 out of 5,494 | 42nd |
Major group Chemicals And Allied Products | 1,422 out of 2,370 | 40th |
Industry group Drugs | 1,266 out of 2,091 | 40th |
Industry Pharmaceutical Preparations | 929 out of 1,538 | 40th |
Source: SEC filing on April 29, 2022.
Yoon's colleagues
We found two more compensation records of executives who worked with Bryan Yoon at Terns Pharmaceuticals in 2021.
News
Terns Pharmaceuticals CEO Senthil Sundaram's 2022 pay falls 37% to $2M
April 28, 2023
Terns Pharmaceuticals CEO Senthil Sundaram's 2021 pay falls 77% to $3.1M
April 29, 2022
LogicBio Therapeutics CEO Frederic Chereau's 2020 pay jumps 193% to $1.9M
April 27, 2021
LogicBio Therapeutics Senior Vice President, Head of Clinical Development Kenneth Huttner receives $765K in 2019
April 29, 2020